Skip to main content
. 2021 Jan 15;10:581459. doi: 10.3389/fonc.2020.581459

Figure 1.

Figure 1

HeyL promotes angiogenesis in transgenic mice. (A) Anti-CD31 IHC analysis of blood vessels in mammary glands of 13 week-old virgin, MMTV-HeyL transgenic mice compared to parental FVB/N mice (n=4 mice/group). (B) Number of blood vessels, vessel length and average area occupied by blood vessels in mammary glands from MMTV-HeyL and parental FVB/N mice, analyzed in (A). (C) Mammary tumors arising spontaneously in MMTV-HeyL/Her2-neu are larger compared to those in MMTV-Her2-neu mice (n=22/group). Measurement was initiated after detection of palpable tumors. (D) Anti-CD31 IHC analysis of blood vessels in mammary tumors in MMTV-HeyL/Her2-neu compared to MMTV-Her2-neu mice from (C), (n=6 mice each group) (E). Number of blood vessels, vessel length and average area occupied by blood vessels in mammary tumors in MMTV-HeyL/Her2-neu mice compared to MMTV-Her2-neu mice from (D) *P < 0.05; **< 0.05.